People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Checkerspot, Inc. | — | Other | Series B | $85.9M | $33.4M | 2020 |
| DNAlite Therapeutics, Inc. | — | Biotechnology | Series A | $5.6M | $87.1M | 2022 |
Andrew Cain McClary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Cain McClary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Kim | 1 | 10 |
| Julia Moore | 1 | 3 |
| Cain McClary | 1 | 3 |
| Scott Franklin | 1 | 3 |
| Walter Solomon | 1 | 1 |
| David Greenwood | 1 | 1 |
| Charles Dimmler | 1 | 1 |
| Mubhij Ahmad | 1 | 1 |
| David Cain Rabuka | 1 | 1 |
| Timothy Paul Day | 1 | 1 |
| Drew Cain Lanza | 1 | 1 |
| John Krzywicki | 1 | 1 |
| Eric Hartz | 1 | 1 |
| Layla Ward | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.